Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 4711 AL 4725

Adult hippocampal neurogenesis and its impairment in Alzheimer's disease

Kim TA, Syty MD, Wu K, Ge S.

Zool Res. 2022 May 18;43(3):481-496. doi: 10.24272/j.issn.2095-8137.2021.479.

Sleep-Wake Disorders in Alzheimer's Disease: A Review

Sun YY, Wang Z, Zhou HY, Huang HC.

ACS Chem Neurosci. 2022 May 18;13(10):1467-1478. doi: 10.1021/acschemneuro.2c00097. Epub 2022 May 4.

Natural Speech Analysis: A Window Into Alzheimer Disease Phenotypes

Agosta F, Filippi M.

Neurology. 2022 Jul 26;99(4):137-138. doi: 10.1212/WNL.0000000000200843. Epub 2022 May 4.

A multi-hit hypothesis for an APOE4-dependent pathophysiological state

Steele OG, Stuart AC, Minkley L, Shaw K, Bonnar O, Anderle S, Penn AC, Rusted J, Serpell L, Hall C, King S.

Eur J Neurosci. 2022 Nov;56(9):5476-5515. doi: 10.1111/ejn.15685. Epub 2022 Jun 6.

Neuroinflammation as a Potential Therapeutic Target in Alzheimer's Disease

Liu P, Wang Y, Sun Y, Peng G.

Clin Interv Aging. 2022 Apr 29;17:665-674. doi: 10.2147/CIA.S357558. eCollection 2022.

Potential role of IP3/Ca(2+) signaling and phosphodiesterases: Relevance to neurodegeneration in Alzheimer's disease and possible therapeutic strategies

Jyoti Dutta B, Singh S, Seksaria S, Das Gupta G, Bodakhe SH, Singh A.

Biochem Pharmacol. 2022 Jul;201:115071. doi: 10.1016/j.bcp.2022.115071. Epub 2022 May 4.

Circadian clocks, cognition, and Alzheimer's disease: synaptic mechanisms, signaling effectors, and chronotherapeutics

Hoyt KR, Obrietan K.

Mol Neurodegener. 2022 May 7;17(1):35. doi: 10.1186/s13024-022-00537-9.

Editorial: Aducanumab Trials EMERGE But Don't ENGAGE

Schneider LS.

J Prev Alzheimers Dis. 2022;9(2):193-196. doi: 10.14283/jpad.2022.37.

Metabolism and the Effect of Animal-Derived Oxysterols in the Diet on the Development of Alzheimer's Disease

Choroszyński M, Barcikowska M, Barczak A.

Ann Nutr Metab. 2022;78(3):125-132. doi: 10.1159/000520514. Epub 2022 May 11.

Resveratrol and neuroprotection: an insight into prospective therapeutic approaches against Alzheimer's disease from bench to bedside

Islam F, Nafady MH, Islam MR, Saha S, Rashid S, Akter A, Or-Rashid MH, Akhtar MF, Perveen A, Md Ashraf G, Rahman MH, Hussein Sweilam S.

Mol Neurobiol. 2022 Jul;59(7):4384-4404. doi: 10.1007/s12035-022-02859-7. Epub 2022 May 12.

Aging, depression and dementia: The inflammatory process

Carrera-González MDP, Cantón-Habas V, Rich-Ruiz M.

Adv Clin Exp Med. 2022 May;31(5):469-473. doi: 10.17219/acem/149897.

Link of BIN1, CLU, and IDE Gene Polymorphisms with the Susceptibility of Alzheimer's Disease: Evidence from a Meta-analysis

Abdul Aziz M, Md Ashraf G, Safiqul Islam M.

Curr Alzheimer Res. 2022;19(4):302-316. doi: 10.2174/1567205019666220511140955.

Lactoferrin as Immune-Enhancement Strategy for SARS-CoV-2 Infection in Alzheimer's Disease Patients

Bartolomé F, Rosa L, Valenti P, Lopera F, Hernández-Gallego J, Cantero JL, Orive G, Carro E.

Front Immunol. 2022 Apr 25;13:878201. doi: 10.3389/fimmu.2022.878201. eCollection 2022.

Trained immunity in viral infections, Alzheimer's disease and multiple sclerosis: A convergence in type I interferon signalling and IFNβ-1a

Vavougios GD, Mavridis T, Artemiadis A, Krogfelt KA, Hadjigeorgiou G.

Biochim Biophys Acta Mol Basis Dis. 2022 Sep 1;1868(9):166430. doi: 10.1016/j.bbadis.2022.166430. Epub 2022 May 10.

Microglia in the Neuroinflammatory Pathogenesis of Alzheimer's Disease and Related Therapeutic Targets

Cai Y, Liu J, Wang B, Sun M, Yang H.

Front Immunol. 2022 Apr 26;13:856376. doi: 10.3389/fimmu.2022.856376. eCollection 2022.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias